Croda International PLC (CRDA) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Croda International PLC stock £26.04, price £36.66, that is 29.0% below the price, quality 60 out of 100. Rating: overvalued. Calculated from audited financials with 25 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 8, 2026.
How to read this chart
60‑month range £23.22 – £90.95 · fair‑value band £16.67 – £35.88 · the £36.66 price screens above the £26.04 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 8, 2026.
Follow Croda International in your weekly email
Every Wednesday you see whether Croda International is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Croda International Plc engages in the consumer care, life science, and industrial specialty businesses in Europe, the Middle East, Africa, North America, Asia, and Latin America.
Show moreShow less
The company offers consumer care products across beauty care, beauty actives, and home care products, as well as fragrances and flavours. It also provides biologics drug delivery, crop protection, and seed coating systems and enhancement technologies to improve germination.
In addition, the company offers industrial specialties, including phase change materials; surfactants, such as emulsifiers, dispersants, wetting agents, detergents, and polymerics; and formulated textile and spin finishes.
Croda International Plc was incorporated in 1925 and is headquartered in Goole, the United Kingdom.
Stock analysis
Croda International PLC (CRDA) currently trades at £36.66, while our model-based Fair Value estimate is £26.04, 29% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of £16.99 per share, and 0 of the 25 models we run sit above the £36.66 price.
Bear case: the Asset-Based group reads lowest at £4.34, and 25 of the 25 models stay below the price. Data coverage for this calculation is high.
Scenario range: £16.67 (bear) to £35.88 (bull), the price of £36.66 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 60/100 (solid quality), in the Basic Materials sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Croda International PLC reported revenue of £1.7B in FY2025 versus £1.9B in FY2021, a compound −2.6%/yr. Reported net income was £62.0M in FY2025, compounding −33.7%/yr from FY2021.
Key figures
Market cap £5.1B Mid · P/E ratio 63.8 · P/S ratio 2.97 · EPS (TTM) £0.5700 · Dividend yield 3.0% · Net margin 4.6% · Return on equity 3.7% · Return on assets (EBIT) 9.4% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 41 out of 100 (low confidence).
What moves the price
The share trades at its 52-week high and 51% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −43% fair-value upside, at −29%, CRDA screens cheaper than that median.
Fair Value models
Bear£16.67Fair Value £26.04Bull£35.88
Price £36.66 · Downside -29.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF£11.58£17.11£24.4278
Growth DCF£11.86£16.88£23.2376
EPV£11.35£13.36£15.0774
All 25 models by family
DCF Models
FCF DCF£11.58£17.11£24.4278
Owner Earnings£4.75£7.52£11.1973
5Y Revenue Exit£10.54£16.83£24.5770
5Y EBITDA Exit£14.16£23.32£33.6072
5Y P/E Exit£6.24£9.12£11.9469
10Y Revenue Exit£10.49£16.02£22.8764
10Y EBITDA Exit£12.99£20.22£29.1866
10Y P/E Exit£8.26£11.04£14.0463
Earnings-Based
Graham-Dodd£3.03£7.46£9.6763
PEG = 1.0£1.35£1.93£2.5055
EPV£11.35£13.36£15.0774
Dividend Discount
Gordon GGM£9.30£16.02£23.7765
DDM Multi-Stage£9.30£13.55£17.8065
Multiples
P/E Multiple£5.67£7.56£9.4563
P/S Multiple£5.67£7.56£9.4558
P/B Multiple£14.58£19.44£24.3055
EV/EBIT£14.60£20.72£26.8465
EV/EBITDA£16.73£23.56£30.3967
EV/Revenue£9.05£14.53£20.0253
Asset-Based
NCAV (Graham)£3.24£4.34£6.4854
Growth DCF
Growth DCF£11.86£16.88£23.2376
Rev-Margin DCF£10.54£16.99£24.0170
Economic Profit
Residual Income£10.79£10.75£11.0674
ROIC Compounder£11.35£13.36£15.0770
Growth Earnings
Growth-Adj P/E£4.43£6.33£8.2365
The fair value above starts from this blend and is adjusted for a cyclical trough year.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+4.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−6.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.1%
Start year 2020 (pandemic). Over 10 years: +4.6% a year
Revenue growth 40 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.6%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis.
−4.6%
Earnings growth per share plus dividend.
Earnings per share, growth per year−7.6%
Dividend (yield on the price)3.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−23.8% vs −10.9%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.22% → 14%
Pace: the 5-year rate starts in 2020 (pandemic)
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+19.6%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+4.3%
Yearly sales growth analysts expect, extended to five years.
After inflation (UK: IMF forecast 2.3% a year to 2030, 3.3% from 2016 to 2025) that is about +16.9% a year for the price and +1.9% for the forecasts.
News mood ⓘNews mood, the average tone of recent news (92 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Hype
Recent news coverage is unusually upbeat, far more positive than stocks are typically covered.
AI conclusion: Croda's expansion into bio-based ingredients for beauty and hair care strengthens its consumer care focus, yet thin evidence of a durable moat and low ROE continue to weigh on quality.
Main risk: Competitors such as BASF with scale in surfactants and Evonik with biotech platforms might capture share or force lower prices in Croda's consumer care and beauty ingredients, hitting margins on differentiated specialties.
Bull case: By advancing its new global biotech research center and AI-supported ingredient discovery Croda could strengthen differentiation in bio-based beauty and hair care actives and retain premium customers against larger rivals.
Bear case: If rivals scale cheaper or broader sustainable alternatives Croda might lose customers in its key consumer care segment to more cost-effective options and see slower growth in bio-based innovation.
Croda is expanding its biotechnology capabilities with a new global research center focused on bio-based ingredients for beauty and hair care applications. This aligns with recent strength in Consumer Care but arrives while our models see the business as overvalued. Will the push into sustainable biotech innovation generate superior returns, or will ongoing transformation efforts and economic uncertainty limit the upside?
Compare Croda International PLC with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 727 stocks
Beats the industry median on 4/15 measures
Overall it trails its industry peers.
Valuation
Quality Score60 · Above median
Fair Value upside−29.0% · Below median
Profitability
Return on equity (12 months)3.7% · Below median
Return on assets1.8% · Below median
Net margin (12 months)4.6% · Below median
Operating margin (12 months)16.1% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)2.9% · Below median
Dividend yield (12 months)3.0% · Top 25%
Balance sheet
Debt / equity0.22× · Above median
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
P/E (12 months)63.8× · Priciest 25%
P/B2.34× · Pricier than median
P/S (12 months)2.97× · Priciest 25%
Price / free cash flow (fiscal year)29.8× · Pricier than median
EV/EBITDA22.2× · Priciest 25%
PEG0.48× · Cheapest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)15· sector 67
PAST (return on equity)15· sector 26
HEALTH (low debt)89· sector 95
DIVIDEND (yield)61· sector 30
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Croda International PLC Fair Value". https://www.fairvalue-calculator.com/stock/CRDA
Frequently asked questions
Is Croda International PLC (CRDA) overvalued or undervalued?
As of Nov 8, 2026, our model estimates a fair value of £26.04 versus a price of £36.66, about 29% lower (overvalued).
What is the fair value of CRDA?
Our model-based fair value for Croda International PLC is £26.04 (as of Nov 8, 2026), built from audited fundamentals. The current price: £36.66.
What is the quality score of CRDA?
Croda International PLC has a Quality Score of 60/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Croda International PLC (CRDA)?
Our model-based price target is the fair value of £26.04 (as of Nov 8, 2026) from 25 valuation models. Cautious scenario £16.67, optimistic scenario £35.88. It is a calculation from audited fundamentals, not an analyst target.
What is the Croda International PLC stock forecast for 2026?
Our models put fair value at £26.04, about 29% lower versus a price of £36.66 (overvalued). Cautious scenario £16.67, optimistic scenario £35.88. The calculation is refreshed regularly with new filings.
What is the revenue of Croda International PLC (CRDA)?
Croda International PLC reported trailing-twelve-month revenue of about £1.7B (latest available figure, as of Nov 8, 2026).
Does Croda International PLC pay a dividend?
Croda International PLC currently shows a dividend yield of 3.03% relative to its recent price (as of Nov 8, 2026).
How much is the dividend of Croda International PLC (CRDA) and when is the ex-dividend date?
Croda International PLC pays a dividend of £1.11 per share a year, a dividend yield of 3.0%. The last ex-dividend date was Aug 27, 2026. A dividend has been paid every year since at least 1993. The payout ratio is 57.8% of earnings (on adjusted earnings, reported 195%). Free cash flow covers the dividend 1.11 times. Our assessment: Well covered. A low payout and the dividend is fully funded by free cash flow, a comfortable, sustainable dividend.
What growth is priced into Croda International PLC (CRDA)?
For today's price to be fair in a discounted-cash-flow model, Croda International PLC would have to grow free cash flow by +19.6 % per year for five years (discount rate 10.1 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +4.1 % per year. As of Nov 8, 2026.
What discount rate (WACC) does the fair value of CRDA use?
Our models discount Croda International PLC at 10.1 %: a base by market capitalisation (mid), damped by beta 0.92, country premium for United Kingdom. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Croda International PLC that is +19.6 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (10.1 %) and the same formula as our fair value.
How much growth has Croda International PLC (CRDA) delivered so far?
Over the past 5 years revenue at Croda International PLC grew +4.1 % a year. The price currently implies free-cash-flow growth of +19.6 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Croda International PLC (CRDA) growing?
The median revenue growth in the sector is +9.8 % a year. That is the yardstick for the growth priced into Croda International PLC (+19.6 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Croda International PLC (CRDA)?
The free-cash-flow yield on the price is 3.35 %: that much free cash flow Croda International PLC produces per unit of market value. When it exceeds the discount rate of our models (10.1 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Croda International PLC (CRDA)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Croda International PLC it is £26.04 per share (as of Nov 8, 2026), against a price of £36.66. It is the blended result of 25 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Croda International PLC stock overvalued or undervalued in 2026?
As of Nov 8, 2026, CRDA trades above its calculated fair value: price £36.66, fair value £26.04, a gap of about −29% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CRDA?
No. The price is what the market pays today (£36.66); the fair value is what the company's own numbers justify (£26.04). For Croda International PLC the two are £10.62 per share apart. That gap is exactly why we show both numbers side by side.
How much is Croda International PLC worth?
The market values Croda International PLC at about £5.1B (market capitalisation, as of Nov 8, 2026). Per share that is £36.66; our models calculate a fair value of £26.04 per share.
What do the bullish and bearish scenarios say about CRDA?
Our models span a range for Croda International PLC: cautious scenario £16.67, base £26.04, optimistic £35.88 per share (as of Nov 8, 2026, price £36.66). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of CRDA?
Croda International PLC trades at a price-to-earnings ratio of 63.8 (as of Nov 8, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of £26.04 is built from several models across several years. Excluding one-off items of fiscal year 2025 it is 25.1 (reported for FY2025: 84.5). Median P/E at fiscal year-end, 7 fiscal years (2019 to 2025), reported earnings, FY2025 ex one-offs: 29.8. Other multiples: PEG 0.5, P/B 2.3, P/S 3.0, EV/EBITDA 22.2.
What is the PEG ratio of CRDA?
The PEG ratio of Croda International PLC is 0.48 (P/E divided by earnings growth, as of Nov 8, 2026). That is below 1, so growth is priced more cheaply than the earnings multiple alone suggests.
How solid is the balance sheet of Croda International PLC (CRDA)?
Balance-sheet figures for Croda International PLC (as of Nov 8, 2026): return on equity 3.7%, debt of 0.22 per unit of equity. They feed the Quality Score of 60/100, which measures business quality independently of the share price.
How far is CRDA from its 52-week high?
Croda International PLC trades at £36.66, at its 52-week high of £36.68 and 51% above the low of £24.31 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of £26.04 is for.
Which stocks are comparable to Croda International PLC?
From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Nan Ya Plastics Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Croda International PLC stock attractive at the current price?
The data as of Nov 8, 2026: price £36.66, calculated fair value £26.04 (−29%), Quality Score 60/100, from 25 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CRDA calculated?
We run Croda International PLC through 25 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of £26.04 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. Croda International PLC itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Croda International PLC (CRDA)?
The closing price on Nov 6, 2026 was £36.66. Our model-based fair value is £26.04, about 29% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Croda International PLC right now?
The price sits above even our optimistic bull case (£35.88). The favourable scenario is already priced in. Solid but not exceptional quality (60/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (£16.67 to £35.88) leaves room in how you read the outcome.
Where does the earnings growth of Croda International PLC (CRDA) come from?
Earnings per share at Croda International PLC grew −4.4 % a year from 2014 to 2025. Broken into its drivers: revenue per share +3.6 %, EBIT margin −5.2 %, tax rate +0.3 %, residual (interest, one-offs) −3.0 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Croda International PLC
How large is the market capitalisation of Croda International PLC (CRDA)?
The market capitalisation of Croda International PLC is £5.1B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Croda International PLC (CRDA)?
The price-to-sales ratio of Croda International PLC is 2.97 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Croda International PLC (CRDA)?
Earnings per share at Croda International PLC are £0.5700 (price ÷ EPS = P/E 63.8). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Croda International PLC (CRDA)?
The dividend yield of Croda International PLC is 3.0% (payout 57.8%, on adjusted earnings, reported 195%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Croda International PLC (CRDA)?
The net margin of Croda International PLC is 4.6% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Croda International PLC (CRDA)?
The return on equity (ROE) of Croda International PLC is 3.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Croda International PLC (CRDA)?
On an EBIT basis the return on assets of Croda International PLC is 9.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Croda International PLC (CRDA)?
The operating margin of Croda International PLC is 16.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Croda International PLC (CRDA)?
Revenue at Croda International PLC is growing +2.9% versus a year earlier (3y avg −6.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Croda International PLC (CRDA)?
Earnings per share at Croda International PLC are growing +28.5% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Croda International PLC (CRDA) carry?
The net debt of Croda International PLC is £524M (fiscal year 2025, ≈ 3.0 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Croda International PLC in the live analysis
One click puts Croda International PLC on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 8, 2026